Literature DB >> 10729080

Bovine viral diarrhea virus: its effects on estradiol, progesterone and prostaglandin secretion in the cow.

M D Fray1, G E Mann, M C Clarke, B Charleston.   

Abstract

Bovine viral diarrhea virus (BVDV) is a major cattle pathogen responsible for a spectrum of symptoms, including reproductive failure. This study was designed to establish the effects of BVDV infection on estradiol, progesterone and PGF2alpha secretion in the cow. Seven BVDV-free cows were challenged with non-cytopathogenic BVDV (strain Pe 515: 5x10(6) tissue culture infected dose50) so that peak viremia occurred during the initial phase of luteal development in a synchronized estrous cycle. Ovulation was also synchronized in 7 sham-infected animals. Within 2 wk of inoculation, viremia, leukopenia and serum neutralizing antibodies were recorded in all of the BVDV-infected cows but not the sham-infected animals. Between Day 4 and Day 9 post estrus the BVDV-infected cows had significantly (P<0.01) lower plasma estradiol levels than the sham-infected animals. However, the BVDV infection did not alter rectal temperatures, plasma progesterone concentrations or PGF2alpha secretion 17, 18 and 19 d post estrus. These data highlight a potential causal link between BVDV viremia, endocrine dysfunction and poor fertility in the cow.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10729080     DOI: 10.1016/s0093-691x(99)00096-5

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  2 in total

1.  Alpha/beta and gamma interferons are induced by infection with noncytopathic bovine viral diarrhea virus in vivo.

Authors:  B Charleston; L S Brackenbury; B V Carr; M D Fray; J C Hope; C J Howard; W I Morrison
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Identification of a cell population that produces alpha/beta interferon in vitro and in vivo in response to noncytopathic bovine viral diarrhea virus.

Authors:  L S Brackenbury; B V Carr; Z Stamataki; H Prentice; E A Lefevre; C J Howard; B Charleston
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.